Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae-Reference-Cited by-同舟云学术

Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae

Published:2021-05-28 Issue:8 Volume:74 Page:528-537
ISSN:0021-8820
Container-title:The Journal of Antibiotics
language:en
Short-container-title:J Antibiot

Author:

Ren Huan,Zhang Jingyi,Zhou Jingyi,Xu Congjuan,Fan Zheng,Pan Xiaolei,Li Shouyi,Liang Yuying,Chen Shuiping,Xu Jun,Wang Penghua,Zhang Yanhong,Zhu Guangbo,Liu Huimin,Jin Yongxin,Bai Fang,Cheng Zhihui,Pletzer Daniel,Wu Weihui^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology

Link

http://www.nature.com/articles/s41429-021-00427-0.pdf

Reference40 articles.

1. Jensen TS, Opstrup KV, Christiansen G, Rasmussen PV, Thomsen ME, Justesen DL, et al. Complement mediated Klebsiella pneumoniae capsule changes. Microbes Infect. 2020;22:19–30.

2. Kobayashi SD, DeLeo FR. Re-evaluating the potential of immunoprophylaxis and/or immunotherapy for infections caused by multidrug resistant Klebsiella pneumoniae. Future Microbiol. 2018;13:1343–6.

3. Bassetti M, Righi E, Carnelutti A, Graziano E, Russo A. Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control. Expert Rev Anti Infect Ther. 2018;16:749–61.

4. Himeno H, Nameki N, Kurita D, Muto A, Abo T. Ribosome rescue systems in bacteria. Biochimie. 2015;114:102–12.

5. Huter P, Müller C, Arenz S, Beckert B, Wilson DN. Structural basis for ribosome rescue in bacteria. Trends biochemical Sci. 2017;42:669–80.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KKL-35 inhibits growth of Staphylococcus aureus by systematically changing bacterial phenotypes;Archives of Microbiology;2024-07-12

2. Enhancing bactericidal activities of ciprofloxacin by targeting the trans-translation system that is involved in stress responses in Klebsiella pneumoniae;Archives of Microbiology;2024-03-13

3. The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic;Frontiers in Public Health;2022-12-21

4. Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii;Pharmaceutics;2022-01-05